Showing results (2081-2090 of 3,394) with videos related to

Sort By:
Pageof 340
The Journal of Surgical Research|July 26, 2016
A comparison of preemptive versus standard renal replacement therapy for acute kidney injury after cardiac surgeryXiao-Mei Yang, Guo-Wei Tu, Jian Gao, et al.
Nature Communications|June 13, 2015
Salicylic acid biosynthesis is enhanced and contributes to increased biotrophic pathogen resistance in Arabidopsis hybridsLi Yang, Bosheng Li, Xiao-yu Zheng, et al.
Hypertension (Dallas, Tex. : 1979)|October 13, 2004
Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive ratsJiu-Chang Zhong, Dong-Yang Huang, Yan-Mei Yang, et al.
Journal of Cellular Biochemistry|June 2, 2017
Down-Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide-Induced Glioma Cells Growth Inhibition and Invasion ImpairmentYuqin Chen, Fei Gao, Rong Jiang, et al.
World Journal of Gastroenterology|March 6, 2010
Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinomaPeng Liu, Jia-Mei Yang, Wen-Yang Niu, et al.
Digestive Diseases and Sciences|December 24, 2008
Protection of regenerating liver after partial hepatectomy from carbon tetrachloride hepatotoxicity in rats: roles of mitochondrial uncoupling protein 2 and ATP storesQiong Wu, Dezheng Gong, Nan Tian, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|September 14, 2007
[Correlates of and willingness to participate in HIV voluntary counseling and testing among migrants in a city of Shanxi province]Jin-ling Zhang, Na He, Xue-wu Shen, et al.
European Journal of Pharmacology|May 31, 2011
Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in ratsYousef Yafai, Xiu Mei Yang, Marc Niemeyer, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 11, 2014
Prognostic role of nucleophosmin in colorectal carcinomasYu-Feng Yang, Xi-Ying Zhang, Mei Yang, et al.
Journal of Crohn'S & Colitis|April 7, 2012
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trialEdouard Louis, Robert Löfberg, Walter Reinisch, et al.
Pageof 340